Tongjitang Chinese Medicines, a specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, said Mr Charles Wang submitted his resignation as Chief Financial Officer. He is said to have resigned for personal reasons and not as a result of any disagreement with the Company regarding financial or accounting practices. The resignation will be effective on December 2, 2010.

Mr Charles Wang is expected to stay with the company until December. The Company has commenced an executive search in order to find a replacement.